AGP Executive Report
Last update: 9 hours agoPharma Manufacturing Expansion: WuXi AppTec is ramping global drug manufacturing capacity, boosting 2026 capex by at least 17% to RMB 6.5–7.5bn, with a major new Middletown, Delaware oral-solid facility starting Q4 2026 and sterile/injectables following in Q4 2027. Swiss Energy Storage Push: Switzerland is building a world-scale underground vanadium flow battery (Flexbase with Invinity), targeting ~2.1 GWh storage and up to 1.2 GW output—aimed at powering about 210,000 homes for a day by 2029. Private Markets Stress: Swiss asset manager Partners Group flagged more withdrawal requests and is expected to cap a second fund, echoing broader private credit strain also seen at Blackstone. Swiss Politics & Infrastructure Pressure: Voters decide on a “No 10 Million Switzerland!” initiative to cap population at 10m, arguing it would ease strain on housing, healthcare, education and transport. Corporate/Regulatory Watch: SEBI action against India’s Rajesh Exports raises questions about revenue linked to Switzerland-based Valcambi SA, with potential knock-on effects for incentive schemes.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
